YCBD cbdMD Inc
Price (delayed)
$0.3033
Market cap
$1.9M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.67
Enterprise value
$1.55M
cbdMD, Inc. is one of the world’s leading, most highly trusted health & wellness CBD companies, whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD botanical
Highlights
The net income has soared by 87% YoY and by 27% QoQ
The EPS has soared by 87% year-on-year and by 7% since the previous quarter
The company's debt has shrunk by 52% YoY but it rose by 28% QoQ
YCBD's equity has dropped by 75% year-on-year and by 9% since the previous quarter
cbdMD's gross profit has decreased by 21% YoY
Key stats
What are the main financial stats of YCBD
Market
Valuations
Earnings
Shares outstanding
6.26M
Market cap
$1.9M
Enterprise value
$1.55M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.94
Price to sales (P/S)
0.07
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.08
Revenue
$19.22M
Gross profit
$11.84M
Operating income
-$2.34M
Net income
-$2.69M
EBIT
-$2.67M
EBITDA
-$1.09M
Free cash flow
-$734,628
Per share
Balance sheet
Liquidity
EPS
-$1.67
EPS diluted
-$1.67
Free cash flow per share
-$0.16
Book value per share
$0.32
Revenue per share
$4.22
TBVPS
$1.94
Total assets
$11.54M
Total liabilities
$9.76M
Debt
$1.63M
Equity
$1.78M
Working capital
-$2.81M
Debt to equity
0.91
Current ratio
0.69
Quick ratio
0.35
Net debt/EBITDA
0.32
Margins
Efficiency
Dividend
EBITDA margin
-5.6%
Gross margin
61.6%
Net margin
-14%
Operating margin
-12.2%
Return on assets
-53%
Return on equity
-271.5%
Return on invested capital
-100.7%
Return on capital employed
-112.5%
Return on sales
-13.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
YCBD stock price
How has the cbdMD stock price performed over time
Intraday
-8.92%
1 week
17.65%
1 month
-23.76%
1 year
-66.74%
YTD
-19.12%
QTD
31.87%
Financial performance
How have cbdMD's revenue and profit performed over time
Revenue
$19.22M
Gross profit
$11.84M
Operating income
-$2.34M
Net income
-$2.69M
Gross margin
61.6%
Net margin
-14%
cbdMD's operating income has soared by 88% YoY and by 30% from the previous quarter
The net income has soared by 87% YoY and by 27% QoQ
YCBD's operating margin has soared by 85% year-on-year and by 28% since the previous quarter
The company's net margin has surged by 84% YoY and by 26% QoQ
Growth
What is cbdMD's growth rate over time
Valuation
What is cbdMD stock price valuation
P/E
N/A
P/B
0.94
P/S
0.07
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.08
The EPS has soared by 87% year-on-year and by 7% since the previous quarter
YCBD's equity has dropped by 75% year-on-year and by 9% since the previous quarter
The stock's P/B is 16% above its 5-year quarterly average of 0.9 and 16% above its last 4 quarters average of 0.9
YCBD's P/S is 94% below its 5-year quarterly average of 1.3 and 20% below its last 4 quarters average of 0.1
The revenue has decreased by 18% YoY
Efficiency
How efficient is cbdMD business performance
The company's return on equity has shrunk by 91% YoY and by 33% QoQ
The ROS has soared by 84% year-on-year and by 26% since the previous quarter
The ROA has grown by 46% YoY and by 7% from the previous quarter
YCBD's ROIC is up by 43% YoY but it is down by 32% QoQ
Dividends
What is YCBD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for YCBD.
Financial health
How did cbdMD financials performed over time
The total assets is 18% more than the total liabilities
cbdMD's current ratio has decreased by 44% YoY and by 7% QoQ
The total assets has contracted by 24% YoY but it has grown by 9% from the previous quarter
The company's debt is 9% lower than its equity
The debt to equity has soared by 90% YoY and by 40% QoQ
YCBD's equity has dropped by 75% year-on-year and by 9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.